Sahoo Tapan Kumar, Kar Tushar, Kar Asaranti, Panda Sasmita
Senior Resident, Department of Radiation Oncology, All India Institute of Medical Sciences, Bhubaneswar, Odisha, India.
Professor, Department of Obstetrics and Gynaecology, Sriram Chandra Bhanja Medical College, Cuttack, Odisha, India.
J Clin Diagn Res. 2017 May;11(5):XD01-XD02. doi: 10.7860/JCDR/2017/25262.9860. Epub 2017 May 1.
Sertoli-Leydig Cell Tumour (SLCT) is included under sex-cord stromal tumour of testis or ovary. Ovarian pathology is an extremely rare entity constituting less than 0.5% of all ovarian neoplasms. Majority of the cases present at younger age group, i.e., 2 and 3 decade of life. The clinical presentation depends on either mass effect or excess hormone production. Virillization symptoms are the most common presentation and depend upon the quantity of androgen production. Most of the patients have a unilateral mass without extraovarian spread and present at stage-I. Treatment and prognosis depends on the degree of the differentiation and the stage of the disease. Here, we report a case of SLCT of the ovary in a young female. The patient initially presented with pain abdomen due to mass effect and was treated with conservative surgery followed by adjuvant chemotherapy due to the presence of poorly differentiated pathology with heterologous elements.
支持-间质细胞瘤(SLCT)包含在睾丸或卵巢的性索间质肿瘤中。卵巢病理情况是一种极其罕见的实体,占所有卵巢肿瘤的比例不到0.5%。大多数病例出现在较年轻的年龄组,即20和30岁年龄段。临床表现取决于肿块效应或激素过度分泌。男性化症状是最常见的表现,取决于雄激素的分泌量。大多数患者有单侧肿块,无卵巢外扩散,处于I期。治疗和预后取决于分化程度和疾病分期。在此,我们报告一例年轻女性卵巢SLCT病例。患者最初因肿块效应出现腹痛,接受了保守手术治疗,由于存在伴有异源性成分的低分化病理情况,随后接受了辅助化疗。